News Highlights: Top Company News of the Day
September 24 2018 - 10:15PM
Dow Jones News
Instagram Co-Founders to Step Down From Facebook
The two co-founders of Facebook's popular Instagram app are
stepping down, a surprise move marking continued tumult at the
social-networking giant.
Google CEO to Meet With Top GOP Lawmakers
Google Chief Executive Sundar Pichai plans to appear at a
private meeting of top GOP lawmakers on Friday and again at a
public hearing this year, responding to new scrutiny of the
company's work with China, its market power and alleged bias in its
search results.
BNY Mellon to Wind Down Hedge-Fund Investment Unit
The Bank of New York Mellon Corp. plans to close a
fund-management subsidiary that invested in various hedge funds, as
demand for such investment vehicles wanes.
Boeing Wins Air Force Chopper Deal
Boeing secured a Pentagon contract worth up to $2.4 billion to
provide helicopters for protecting nuclear-missile bases. The
aerospace giant is awaiting the outcome of a larger deal to build
Air Force trainer jets.
Shell CEO Considers Natural-Gas Bet
Ben van Beurden said a consortium led by the energy giant will
decide before year-end whether to proceed with a $30 billion,
liquefied-natural-gas export terminal in western Canada.
Deutsche Bank's German Regulators Show Impatience With Money-Laundering Controls
Germany's financial watchdog ordered Deutsche Bank to bolster
its controls to prevent money laundering in a reprimand that comes
amid a growing focus on European lenders' progress policing
financial crime.
Former Invitation Homes CEO Joins Deutsche Bank
John Bartling, former CEO of Invitation Homes, joined Deutsche
Bank as a senior U.S. banker, in a bid by the bank to boost its
relationships with corporate boards, private-equity firms and other
deal makers.
Big Tech's Business Model Is Broken: Report
Silicon Valley tech giants can't be trusted to police themselves
and should be subject to tougher regulation, including around their
pattern of acquiring competitors to accumulate ever-larger stores
of user data, according to a critical new report released
Monday.
Gilead to Slice List Prices of Liver Drugs
The drugmaker intends to slash the list price of its hepatitis C
treatments as it responds to competitive pricing pressures and
shifts in the U.S. payment system for pharmaceuticals.
Amarin Surges on Fish-Oil Drug Data
Amarin more than tripled in value after the company said its
drug derived from fish oil reduced the risk of heart attacks,
strokes and deaths in certain high-risk patients.
(END) Dow Jones Newswires
September 24, 2018 23:00 ET (03:00 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.